Biosimilars

Drug Shortages and You: Who's At Risk, What's the Fix?

John Horton | Posted 05.09.2012

Read More: Biosimilars, Methotrexate Shortage, Biologics, Legitscript, Fda-Drug-Shortage, Fda-Drug-Recalls, Drug Shortage, Fda Drug Shortage, Drug Shortages, Politics News
John Horton

Drug shortages are a complex problem with multiple causes, not least of all manufacturing issues that can affect the safety of injectable medicines like biologics.

Read Post

Data Exclusivity: Getting the Balance Right

John Horton | Posted 07.19.2011

Read More: Biosimilars, Biologics, Fda Regulations, Intellectual Property, Pharmaceuticals, Politics News
John Horton

What's the right length for data exclusivity? The current law says innovator drug makers have twelve years; in the European Union, it's ten; and the 2012 budget proposes seven. Who's right?

Read Post

Are Unsafes Drugs An 'Acceptable Risk?' FDA Should Say 'No!'

John Horton | Posted 05.25.2011

Read More: Biosimilars, FDA Biologics, FDA Biosimilars, FDA Biologic Drugs, Biosimilar Drugs, Biologic Drugs, Biologics, Home News
John Horton

As a matter of common sense, the FDA's process for biosimilars shouldn't sacrifice patient safety.

Read Post

The 2010 Elections, Reflections, Lessons and Taking Stock

James Love | Posted 05.25.2011

Read More: Biosimilars, Transparency, Copyright Infringement, Howard Dean, Acta, Mysql-Oracle, Ticketmaster Live Nation Merger, Patents, Politics News
James Love

It's hard to develop a public narrative and a legislative record as a champion of the underdog when you spend so much time pandering to giant corporate interests.

Read Post

The White House Deal with Big Pharma

James Love | Posted 05.25.2011

Read More: Biosimilars, Jeffrey Kindler, Phrma, Billy Tauzin, Pfzier, Big Pharma, Pharmaceutical Companies, Pharmaceutical Industry, Max Baucus, Henry Waxman, Politics News
James Love

The White House has abandoned any real effort to control costs in the pharma sector and Democrats have taken this hands-off approach as a green light to side with Big Pharma.

Read Post

Eshoo and Barton Team Up to Block Generic Biologic Medicines

James Love | Posted 05.25.2011

Read More: Biosimilars, Anna Eshoo, Phrma, Eshoo Barton Amendment, PhRMA Lobby, Joe Barton, Henry Waxman, Health Care, Bio, Politics News
James Love

The Eshoo/Barton amendment, which has the support of many newly pro-PhRMA democrats, will extend the period of monopolies for biologic medicines.

Read Post

Howard Dean Claims He Is "Actually Not a Shill For the BIO." Then Stop Acting Like One

James Love | Posted 05.25.2011

Read More: Biosimilars, Howard Dean, Dean BIO, Biotechnology Industry Association, Dean and Biotech, Biotech, Bio, Dean Lobbyist, Politics News
James Love

I have always liked Howard Dean, but nothing excuses what he is doing now.

Read Post

Howard Dean -- Now a Shill for BIO

James Love | Posted 05.25.2011

Read More: Biosimilars, Howard Dean, Joe Trippi, Bio, Jim Greenwood, Politics News
James Love

What exactly would it take to make Howard Dean a lobbyist? A special badge from the Wizard of Oz?

Read Post

Joe Trippi Admits He Works for BIO, While He Plugs BIO Bill in HuffPo

James Love | Posted 05.25.2011

Read More: Biosimilars, Howard Dean, Joe Trippi, Bio, Politics News
James Love

Trippi posted the lame assertion that "I have never been paid by anyone to post or blog anything by anyone." Well, what is BIO paying Joe to do?

Read Post

Key Democrats Back BIO Industry Against Consumers to Delay Generic Medicines (Biosimilars)

James Love | Posted 05.25.2011

Read More: Senator Kennedy, Biosimilars, Anna Eshoo, John Conyers, Generic Medication, Politics News
James Love

Unlike for pharmaceutical drugs, there is no easy way to get FDA approval for a generic biologic product. Congress is considering an FDA reform to fix this, but it is being derailed by the BIO.

Read Post